Litigation cells: Their incidence and classification in gynecologic smears

Wei Sun,W. Grafton

DOI: https://doi.org/10.1002/dc.10122

2002-06-01

Diagnostic Cytopathology

Abstract:“Litigation cells” are defined as benign cells which may mimic dysplasia or cancer and might be used by plaintiffs' witnesses to imply that the cytotechnologist or pathologist “missed” cells of dysplasia or cancer. We reviewed 180 cervical smears from 166 patients who had hysterectomy for benign leiomyomas. All smears were performed within 12 months prior to hysterectomy. None of the uteri contained dysplasia or cancer on histologic examination. 90.6% of smears reviewed had at least one cell or cell group with atypia mimicking dysplasia or cancer. These “litigation cells” were classified as follows: parabasal cells, metaplastic squamous cells, degenerated endocervical cells, reactive endocervical cells, endometrial cells, neutrophils, histiocytes, and air‐dried cells. Diseases mimicked by these cells included squamous cell carcinoma, high‐grade squamous intraepithelial lesion, low‐grade squamous intraepithelial lesion, adenocarcinoma, and glandular dysplasia. These “litigation cells” can be correctly classified by experienced cytotechnologists and cytopathologists and recognized as benign. We recommend that in all cases of alleged malpractice against cytotechnologists and/or pathologists the smears should be reviewed by a panel of individuals trained and experienced in cytopathology. The smears should be reviewed without knowledge of the clinical outcome and in an environment that simulates the normal screening practice. Diagn. Cytopathol. 2002;26:345–348. © 2002 Wiley‐Liss, Inc.